Primary endpoint: Time vs Absolute Numbers
|
2
|
Resverlogix Corp.
|
Nov 19, 2018 11:32AM
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Feb 08, 2019 04:50PM
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Feb 10, 2019 12:33PM
|
Re: Contest Tally
|
1
|
Resverlogix Corp.
|
Feb 11, 2019 08:18PM
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 10:36AM
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 10:54AM
|
Re: Contest Tally
|
2
|
Resverlogix Corp.
|
Feb 19, 2019 05:03PM
|
Re: When to expect the 250th Event
|
3
|
Resverlogix Corp.
|
Feb 27, 2019 12:52AM
|
Re: Mark Day interview with Stock News Now
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 27, 2019 05:33PM
|
Re: Mark Day interview with Stock News Now
|
3
|
BIOASIS TECHNOLOGIES INC
|
Feb 27, 2019 07:13PM
|
Why I think it's a homerun
|
6
|
Resverlogix Corp.
|
Mar 03, 2019 03:34PM
|
Re: Why I think it's a homerun
|
3
|
Resverlogix Corp.
|
Mar 03, 2019 04:34PM
|
Re: A few clarifications from IR
|
1
|
Resverlogix Corp.
|
Mar 06, 2019 11:05AM
|
Re: Top Line Mid Year
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 04:12PM
|
Re: Thoughts ....
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 11, 2019 09:21PM
|
It was planned
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 11, 2019 09:32PM
|
Re: News out
|
3
|
Resverlogix Corp.
|
Mar 18, 2019 01:10PM
|
New Form 45-106F1 Report of Exempt Distribution
|
4
|
Resverlogix Corp.
|
Mar 18, 2019 07:56PM
|
Re: Standard of Care in BETonMACE
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 10:04AM
|
Re: Pulmonary Hypertension News
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 06:17PM
|